NewsBiocon Biologics Inks Pact With Sandoz For Sale Of 2 Biosimilar Products In AustraliaBY Press Trust of India
CorporateBiocon Considers $1.5 Billion Sale Of Generic API Business To Cut DebtBY Outlook Business Desk
NewsOfficial Action Indicated For Biocon Arm's Unit In Malaysia After USFDA InspectionBY Press Trust of India
NewsDeal Street Hits All-Time High Of $130 Billion In First Half Of 2022 On HDFC, Adani-Holcim MergersBY Press Trust of India
NewsBiocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product ApprovalBY Press Trust of India
NewsCBI Arrests Joint Drug Controller For Alleged Bribery To Favour Biocon Biologics' MedicineBY Press Trust of India
NewsCBI Arrests Joint Drugs Controller In Bribery Case To Clear Biocon Biologics InjectionBY Press Trust of India
